Anika Therapeutics, Inc. SEC filings ANIK

Anika Therapeutics, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Dec 19, 2003. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 29, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Anika Therapeutics, Inc. SEC filings
Form Description Filed Period
UPLOAD Letter from the SEC Jul 24, 2025 —
CORRESP Letter to the SEC Jul 17, 2025 —
UPLOAD Letter from the SEC Jun 18, 2025 —
PRER14A Filing Apr 25, 2023 —
PRRN14A Anika therapeutics, inc. Apr 6, 2023 —
UPLOAD Letter from the SEC Apr 5, 2023 —
CORRESP Letter to the SEC Apr 5, 2023 —
PRER14A Filing Apr 5, 2023 —
UPLOAD Letter from the SEC Apr 4, 2023 —
PREC14A Anika therapeutics, inc. Mar 30, 2023 —
PREC14A Filing Mar 27, 2023 —
DFAN14A Anika therapeutics, inc. Feb 21, 2023 —
DEFR14A Filing Jun 1, 2022 —
SEC STAFF LETTER Filing Feb 19, 2020 —
SEC STAFF LETTER Filing Jan 31, 2020 —
DEFR14A Filing May 24, 2016 —
CT ORDER Filing Jan 30, 2012 —
8-A12B Anika therapeutics, inc. 8-a12b Apr 7, 2008 —
UPLOAD Letter from the SEC Dec 11, 2007 —
UPLOAD Letter from the SEC Nov 30, 2007 —
CORRESP Letter to the SEC Nov 29, 2007 —
11-K Employee savings plan report Jun 30, 2004 Dec 31, 2003

Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ANIK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedford, MA
SEC filer status
Accelerated filer
SEC CIK
898437
Former names
ANIKA THERAPEUTICS INC (until Mar 13, 2014); ANIKA RESEARCH INC (until Nov 27, 1996)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.